Ventana Biotech Inc

3 January 2010

Ventana - Sale of IP Update

Ventana Biotech Inc. (”Ventana”) (VNTA.PK) today announced that the closing for the sale of its IP is still ongoing. The terms of the deal have already been agreed and it presents a value as per the date of the original offer and therefore a value significantly higher than what the curre... <read more>

7 December 2009

Ventana Enters Final Stage of Negotiations

Ventana Biotech Inc. (”Ventana”) (VNTA.PK), a biotechnology company developing an appetite-suppressing and stress reducing chewing gum, today announced that it has entered into the final stages of negotiations for the sale of its current IP and product pipeline. As mentioned in a pre... <read more>

Welcome to Ventana Biotech

Ventana Biotech is a early stage biotech company focused on IP discovery and product licensing.

Our mission at Ventana Biotech Inc is to invent innovative intellectual property for medicated chewing gum in the areas of appetite suppressants and stress management and we seek to bring these products to market through partnering with manufactures of medicated chewing gum and other medicated chewing gum distributors.

Ventana Biotech Inc strives to improve the health and quality of life for the average person by eventually making its medicated chewing gum available for over-the-counter sales through partnering up with companies that has already these manufacturing and distribution channels in place. Our strategy is to build on anticipated success of what will be our flagship products and continue to research new areas of opportunities.